Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Non Insulin Based Type II Diabetes Therapy


技术优势

The researchers have developed novel compositions that have been demonstrated to be safe and effective in an animal model of diabetes (rodent) Can be taken orally unlike insulin, eliminating the need for painful injections As a therapy restoring the body's ability to regulate blood glucose on its own, it will lead to better real time glucose management, alleviating the deleterious health effects of hyperglycemia A metabolic precursor to this molecule has been used for five decades to treat unrelated conditions and has proven itself to be safe and well tolerated by patients Has the potential to eliminate the adverse side effects, like hypoglycemia and weight gain, of most current diabetes therapies


技术应用

A new, non-insulin based therapy for type II diabetes to aid the body's native insulin response to blood glucose levels; may be used independently or in conjunction with other therapies Allows for the use of a radiolabeled variant of the inhibitor to target beta cells in the pancreas to quantify progression of disease based on the degree of radioactive labeling


详细技术说明

One of the factors contributing to type II diabetes is impaired beta cell function and loss of response to hyperglycemic stimulus. This technology is a novel inhibitor of an ATP dependent transporter molecule expressed in beta cells, which is respons...


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版